Clinical Trial Detail

NCT ID NCT02582359
Title MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

acute myeloid leukemia

Therapies

Cytarabine + Daunorubicin + Ixazomib

Age Groups: adult senior

No variant requirements are available.